Trials / Conditions / Stage IIIA2 Ovarian Cancer AJCC v8

Stage IIIA2 Ovarian Cancer AJCC v8

13 registered clinical trials studyying Stage IIIA2 Ovarian Cancer AJCC v8 — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Withdrawn	Specialized Immune Cells (nCTLs) and a Vaccine (Alpha-type-1 Polarized Dendritic Cells) in Treating Patients W NCT03735589	Roswell Park Cancer Institute	Phase 1 / Phase 2
Recruiting	Hyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Tr NCT05415709	Ohio State University Comprehensive Cancer Center	EARLY_Phase 1
Recruiting	Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Pa NCT05092373	M.D. Anderson Cancer Center	Phase 1
Recruiting	Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors NCT07259304	University of Southern California	—
Recruiting	IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors NCT05039801	M.D. Anderson Cancer Center	Phase 1
Recruiting	Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer NCT04794322	Massachusetts General Hospital	—
Completed	Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes NCT04501913	City of Hope Medical Center	—
Completed	Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study NCT03707574	National Cancer Institute (NCI)	—
Active Not Recruiting	Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cance NCT03943173	M.D. Anderson Cancer Center	EARLY_Phase 1
Active Not Recruiting	Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer NCT03939481	SWOG Cancer Research Network	—
Active Not Recruiting	Modified Immune Cells (Autologous CAR T Cells) in Treating Patients with Advanced, Recurrent Platinum Resistan NCT03907527	Precigen, Inc	Phase 1
Terminated	Lavage of the Uterine Cavity for Diagnosis of Ovarian Cancer NCT03606486	University of Washington	N/A
Active Not Recruiting	Gene-Modified T Cells With or Without Decitabine in Treating Patients With Advanced Malignancies Expressing NY NCT02650986	Roswell Park Cancer Institute	Phase 1 / Phase 2